NWU Institutional Repository

In silico modelling in the development of novel radiolabelled peptide probes

Loading...
Thumbnail Image

Date

Journal Title

Journal ISSN

Volume Title

Publisher

Bentham Science

Abstract

This review describes the usefulness of in silico design approaches in the design of new radiopharmaceuticals, especially peptide-based radiotracers (including peptidomimetics). Although not part of the standard arsenal utilized during radiopharmaceutical design, the use of in silico strategies is steadily increasing in the field of radiochemistry as it contributes to a more rational and scientific approach. The development of new peptide-based radiopharmaceuticals as well as a short introduction to suitable computational approaches are provided in this review. The first section comprises a concise overview of the three most useful computeraided drug design strategies used, namely i) a Ligand-based Approach (LBDD) using pharmacophore modelling, ii) a Structure-based Design Approach (SBDD) using molecular docking strategies and iii) Absorption-Distribution-Metabolism-Excretion-Toxicity (ADMET) predictions. The second section summarizes the challenges connected to these computer-aided techniques and discusses successful applications of in silico radiopharmaceutical design in peptide-based radiopharmaceutical development, thereby improving the clinical procedure in Nuclear Medicine. Finally, the advances and future potential of in silico modelling as a design strategy is highlighted

Description

Citation

Kleynhans, J. et al. 2020. In silico modelling in the development of novel radiolabelled peptide probes. Current medicinal chemistry, 27(41):7048-7063. [https://doi.org/10.2174/0929867327666200504082256]

Endorsement

Review

Supplemented By

Referenced By